Study to Safety, Tolerability and Immunogenicity of EG-COVII in Healthy Adult

Individualised Dose Optimisation of Ganciclovir in Immunocompromised Children Trial (ID-MAGIC)

NCT06574789 ·Status: RECRUITING ·Phase: PHASE2

Trial to Evaluate the Safety and Immunogenicity of a Modified Vaccinia Ankara (MVA)-Based Anti-Cytomegalovirus (CMV) Vaccine (Triplex®)

NCT05099965 ·Status: COMPLETED ·Phase: PHASE2

Safety, Tolerability, and Immunogenicity of the Human Cytomegalovirus Vaccine (V160) in Healthy Adults (V160-001)

NCT01986010 ·Status: COMPLETED ·Phase: PHASE1

Suppression of Cytomegalovirus Retinitis Utilizing High Dose Intravenous Acyclovir and Oral Zidovudine in Patients With AIDS

NCT00000693 ·Status: COMPLETED ·Phase: NA

A Treatment Protocol for the Use of Intravenous Ganciclovir in AIDS Patients With Immediately Sight-Threatening CMV Retinitis

NCT00000698 ·Status: COMPLETED ·Phase: PHASE3

Vaccine Therapy in Healthy Volunteers With or Without Previous Exposure to Cytomegalovirus

NCT01941056 ·Status: COMPLETED ·Phase: PHASE1

Prevalence of SARS-CoV-2 Genome in Tears of Asymptomatic and Moderately Symptomatic COVID-19 Patients

NCT04654325 ·Status: TERMINATED ·Phase: NA

Study to Evaluate Safety and Immunogenicity of the GSK Bio CMV Vaccine in CMV-seronegative Healthy Male Adult Subjects

NCT00435396 ·Status: COMPLETED ·Phase: PHASE1

Studies of Ocular Complications of AIDS (SOCA)--Ganciclovir-Cidofovir CMV Retinitis Trial (GCCRT)

NCT00000143 ·Status: COMPLETED ·Phase: PHASE3

Safety, Tolerability, and Immunogenicity of a Cytomegalovirus DNA Vaccine

NCT02594566 ·Status: WITHDRAWN ·Phase: PHASE1

Prophylaxis Guided by Cytomegalovirus-specific T Cell Immunity to Prevent Cytomegalovirus Disease in Lung Transplant Recipients

NCT06494033 ·Status: RECRUITING

A Randomized, Controlled Study of Intravenous Ganciclovir Therapy for Peripheral Cytomegalovirus Retinitis in Patients With AIDS

NCT00000688 ·Status: COMPLETED ·Phase: PHASE3

A Clinical Trial of an Alphavirus Replicon Vaccine for Cytomegalovirus (CMV)

NCT00439803 ·Status: COMPLETED ·Phase: PHASE1

A Long-Term Extension Study to Evaluate the Immunogenicity and Safety of Cytomegalovirus (CMV) mRNA-1647 Vaccine

NCT04975893 ·Status: COMPLETED ·Phase: PHASE2

A Phase I/II Trial to Assess the Safety and Tolerance of Escalating Doses of a Human Anti-Cytomegalovirus Monoclonal Antibody (SDZ MSL-109) in Patients With the Acquired Immunodeficiency Syndrome and CMV Retinitis

NCT00002016 ·Status: COMPLETED ·Phase: PHASE1

The Safety and Effectiveness of Ganciclovir Used Alone or in Combination With Granulocyte-Macrophage Colony Stimulating Factor in the Treatment of Cytomegalovirus (CMV) of the Eye in Patients With AIDS

NCT00000989 ·Status: COMPLETED ·Phase: NA

A Study of Human Cytomegalovirus (HCMV) Vaccine SPYVLP01 With and Without Adjuvants

NCT06145178 ·Status: COMPLETED ·Phase: PHASE1

Safety, Reactogenicity, and Immunogenicity of Cytomegalovirus Vaccines mRNA-1647 and mRNA-1443 in Healthy Adults

NCT03382405 ·Status: COMPLETED ·Phase: PHASE1

A Study of Safety and Immune Response to Different Doses of a Cytomegalovirus Vaccine in Healthy Adults

NCT05089630 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Trial to Evaluate Safety and Immunogenicity of a Vaccine Against HCMV

NCT02798692 ·Status: COMPLETED ·Phase: PHASE1

A Study on Cytomegalovirus (CMV) Infection Outcomes Among Solid Organ Transplant (SOT) Participants in Europe and Canada

NCT05576805 ·Status: COMPLETED

Comparison of Two Methods in the Treatment of Cytomegalovirus of the Eyes in Patients With AIDS

NCT00001061 ·Status: COMPLETED ·Phase: PHASE2

Study of Monoclonal Antibodies for Early Etiotropic Therapy for Coronavirus Infection Caused by the SARS-CoV-2 Virus

NCT05729360 ·Status: UNKNOWN ·Phase: PHASE2

Ocular Pathogen and Transcriptome Investigation Using Comprehensive Sequencing

NCT05286203 ·Status: RECRUITING ·Phase: NA

Studies of the Ocular Complications of AIDS (SOCA)--Monoclonal Antibody CMV Retinitis Trial (MACRT)

NCT00000135 ·Status: COMPLETED ·Phase: PHASE2/PHASE3